| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, Bacterial | 14 | 2020 | 159 | 4.280 |
Why?
|
| Bacterial Toxins | 14 | 2020 | 265 | 3.830 |
Why?
|
| Sjogren's Syndrome | 21 | 2025 | 261 | 3.140 |
Why?
|
| Anthrax | 9 | 2024 | 85 | 2.970 |
Why?
|
| Ribonucleoproteins | 15 | 2021 | 153 | 2.720 |
Why?
|
| Autoantigens | 15 | 2021 | 212 | 2.670 |
Why?
|
| Bacillus anthracis | 9 | 2024 | 146 | 2.640 |
Why?
|
| Antibodies, Bacterial | 10 | 2020 | 100 | 2.540 |
Why?
|
| Anthrax Vaccines | 10 | 2020 | 34 | 2.530 |
Why?
|
| Antibodies, Neutralizing | 5 | 2020 | 69 | 1.890 |
Why?
|
| Salivary Glands, Minor | 4 | 2021 | 21 | 1.450 |
Why?
|
| Lupus Erythematosus, Systemic | 12 | 2021 | 988 | 1.370 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2016 | 45 | 1.230 |
Why?
|
| Autoimmunity | 9 | 2021 | 154 | 1.190 |
Why?
|
| B-Lymphocytes | 11 | 2021 | 278 | 1.180 |
Why?
|
| Immunoglobulin G | 14 | 2020 | 267 | 1.170 |
Why?
|
| Epitopes, B-Lymphocyte | 4 | 2013 | 24 | 1.030 |
Why?
|
| Epitopes, T-Lymphocyte | 5 | 2023 | 45 | 1.020 |
Why?
|
| Toll-Like Receptors | 3 | 2012 | 22 | 1.010 |
Why?
|
| Mice | 31 | 2021 | 4468 | 0.980 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2023 | 101 | 0.910 |
Why?
|
| Antibodies, Antinuclear | 10 | 2023 | 181 | 0.880 |
Why?
|
| Autoantibodies | 11 | 2023 | 472 | 0.870 |
Why?
|
| Epitopes | 6 | 2021 | 177 | 0.850 |
Why?
|
| Immunity, Humoral | 5 | 2020 | 46 | 0.840 |
Why?
|
| Macrophages | 5 | 2024 | 280 | 0.830 |
Why?
|
| Animals | 35 | 2021 | 10074 | 0.800 |
Why?
|
| Antibody Specificity | 6 | 2021 | 114 | 0.770 |
Why?
|
| Interferon Type I | 3 | 2017 | 55 | 0.770 |
Why?
|
| Humans | 47 | 2025 | 27159 | 0.720 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2020 | 9 | 0.690 |
Why?
|
| Neutralization Tests | 7 | 2020 | 32 | 0.670 |
Why?
|
| Phagocytosis | 1 | 2019 | 79 | 0.610 |
Why?
|
| Female | 28 | 2025 | 14648 | 0.610 |
Why?
|
| Mice, Inbred C57BL | 13 | 2021 | 1494 | 0.600 |
Why?
|
| Immune Tolerance | 7 | 2015 | 49 | 0.600 |
Why?
|
| Lymphocyte Activation | 7 | 2020 | 205 | 0.590 |
Why?
|
| Neutrophils | 1 | 2019 | 179 | 0.580 |
Why?
|
| c-Mer Tyrosine Kinase | 3 | 2024 | 13 | 0.580 |
Why?
|
| RNA | 5 | 2021 | 106 | 0.560 |
Why?
|
| Middle Aged | 18 | 2025 | 6913 | 0.560 |
Why?
|
| Dendritic Cells | 2 | 2016 | 143 | 0.530 |
Why?
|
| Adipose Tissue | 1 | 2017 | 181 | 0.510 |
Why?
|
| Adult | 18 | 2025 | 7505 | 0.510 |
Why?
|
| Mice, Transgenic | 9 | 2021 | 490 | 0.500 |
Why?
|
| Interleukin-6 | 2 | 2014 | 190 | 0.490 |
Why?
|
| Ribosomes | 1 | 2015 | 31 | 0.480 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2015 | 18 | 0.470 |
Why?
|
| Nephritis | 1 | 2014 | 10 | 0.470 |
Why?
|
| ADAM Proteins | 1 | 2015 | 102 | 0.460 |
Why?
|
| Male | 19 | 2025 | 13029 | 0.460 |
Why?
|
| Lymphocytes | 1 | 2014 | 83 | 0.450 |
Why?
|
| Genes, MHC Class II | 1 | 2012 | 10 | 0.420 |
Why?
|
| Lung | 2 | 2014 | 360 | 0.400 |
Why?
|
| T-Lymphocytes | 4 | 2025 | 280 | 0.390 |
Why?
|
| Gene Expression Regulation | 4 | 2017 | 627 | 0.390 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2015 | 216 | 0.390 |
Why?
|
| Receptors, Antigen, B-Cell | 3 | 2012 | 34 | 0.390 |
Why?
|
| Signal Transduction | 5 | 2021 | 1374 | 0.370 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 1405 | 0.370 |
Why?
|
| B-Lymphocyte Subsets | 2 | 2008 | 30 | 0.360 |
Why?
|
| Histocompatibility Antigens Class II | 4 | 2013 | 58 | 0.350 |
Why?
|
| Apoptosis | 4 | 2021 | 738 | 0.340 |
Why?
|
| Aging | 1 | 2017 | 960 | 0.340 |
Why?
|
| Spleen | 2 | 2007 | 109 | 0.330 |
Why?
|
| Clonal Anergy | 2 | 2008 | 11 | 0.330 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 2 | 2021 | 15 | 0.330 |
Why?
|
| Kidney Glomerulus | 1 | 2009 | 15 | 0.330 |
Why?
|
| Complement C3 | 1 | 2009 | 21 | 0.330 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2009 | 17 | 0.330 |
Why?
|
| Young Adult | 6 | 2020 | 2634 | 0.330 |
Why?
|
| Membrane Glycoproteins | 2 | 2010 | 143 | 0.320 |
Why?
|
| HLA-DQ Antigens | 1 | 2007 | 25 | 0.290 |
Why?
|
| Genome-Wide Association Study | 3 | 2022 | 239 | 0.290 |
Why?
|
| HLA-DR Antigens | 1 | 2007 | 29 | 0.290 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2023 | 75 | 0.290 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2007 | 24 | 0.290 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2007 | 31 | 0.290 |
Why?
|
| Albuminuria | 1 | 2007 | 23 | 0.280 |
Why?
|
| B-Cell Activating Factor | 1 | 2007 | 31 | 0.280 |
Why?
|
| Biopsy | 2 | 2017 | 201 | 0.270 |
Why?
|
| Mice, Inbred Strains | 3 | 2013 | 61 | 0.270 |
Why?
|
| Transcriptome | 2 | 2021 | 205 | 0.260 |
Why?
|
| Prognosis | 3 | 2017 | 762 | 0.260 |
Why?
|
| Salivary Glands | 2 | 2018 | 51 | 0.260 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 365 | 0.250 |
Why?
|
| Superantigens | 1 | 2005 | 6 | 0.250 |
Why?
|
| Enterotoxins | 1 | 2005 | 21 | 0.250 |
Why?
|
| Bacterial Proteins | 1 | 2009 | 474 | 0.250 |
Why?
|
| Flow Cytometry | 3 | 2015 | 285 | 0.240 |
Why?
|
| Fatigue | 1 | 2025 | 63 | 0.230 |
Why?
|
| Cell Polarity | 2 | 2019 | 22 | 0.230 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2015 | 254 | 0.230 |
Why?
|
| Aged | 7 | 2025 | 5229 | 0.230 |
Why?
|
| Mutation | 2 | 2008 | 822 | 0.230 |
Why?
|
| Cell Line | 5 | 2023 | 680 | 0.230 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 1 | 2024 | 6 | 0.230 |
Why?
|
| Epitope Mapping | 3 | 2021 | 38 | 0.230 |
Why?
|
| Antigens, Nuclear | 1 | 2003 | 22 | 0.220 |
Why?
|
| Peptidoglycan | 1 | 2024 | 47 | 0.220 |
Why?
|
| Cell Wall | 1 | 2024 | 64 | 0.220 |
Why?
|
| Case-Control Studies | 3 | 2025 | 708 | 0.220 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2003 | 34 | 0.210 |
Why?
|
| Oxygen | 2 | 2021 | 230 | 0.210 |
Why?
|
| Oxidation-Reduction | 2 | 2021 | 353 | 0.210 |
Why?
|
| Recombinant Proteins | 3 | 2021 | 408 | 0.210 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 438 | 0.210 |
Why?
|
| Autoimmune Diseases | 5 | 2021 | 162 | 0.210 |
Why?
|
| Cells, Cultured | 3 | 2019 | 976 | 0.200 |
Why?
|
| Antigen-Presenting Cells | 3 | 2023 | 31 | 0.200 |
Why?
|
| Mitochondria | 1 | 2025 | 333 | 0.190 |
Why?
|
| Molecular Sequence Data | 7 | 2010 | 1041 | 0.190 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2021 | 17 | 0.190 |
Why?
|
| Conserved Sequence | 2 | 1999 | 54 | 0.190 |
Why?
|
| Cytoplasm | 2 | 2021 | 57 | 0.190 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 93 | 0.180 |
Why?
|
| Nucleic Acid Conformation | 2 | 1999 | 90 | 0.180 |
Why?
|
| RNA, Small Cytoplasmic | 5 | 2000 | 63 | 0.180 |
Why?
|
| Antibody-Producing Cells | 2 | 2018 | 15 | 0.180 |
Why?
|
| Cell Nucleus | 1 | 2021 | 135 | 0.180 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 262 | 0.180 |
Why?
|
| Thymus Gland | 2 | 2015 | 53 | 0.180 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 75 | 0.180 |
Why?
|
| RNA, Messenger | 3 | 2015 | 647 | 0.180 |
Why?
|
| Turkey | 1 | 2020 | 9 | 0.170 |
Why?
|
| Cell Communication | 1 | 2021 | 66 | 0.170 |
Why?
|
| Base Sequence | 5 | 2007 | 575 | 0.170 |
Why?
|
| Antigen Presentation | 2 | 2015 | 78 | 0.170 |
Why?
|
| Nucleic Acids | 2 | 2012 | 10 | 0.170 |
Why?
|
| Immunization | 3 | 2021 | 118 | 0.160 |
Why?
|
| Receptors, Vitronectin | 1 | 2019 | 4 | 0.160 |
Why?
|
| Vertebrates | 2 | 1999 | 18 | 0.160 |
Why?
|
| Protein S | 1 | 2019 | 26 | 0.160 |
Why?
|
| Interleukin-4 | 1 | 2019 | 23 | 0.160 |
Why?
|
| Milk Proteins | 1 | 2019 | 18 | 0.160 |
Why?
|
| Pandemics | 1 | 2020 | 176 | 0.160 |
Why?
|
| Epithelial Cells | 1 | 2021 | 240 | 0.160 |
Why?
|
| Antigens, Surface | 1 | 2019 | 39 | 0.160 |
Why?
|
| Coculture Techniques | 1 | 2019 | 54 | 0.160 |
Why?
|
| ROC Curve | 2 | 2017 | 137 | 0.160 |
Why?
|
| Dexamethasone | 1 | 2019 | 54 | 0.160 |
Why?
|
| Cyclic AMP | 1 | 2019 | 83 | 0.160 |
Why?
|
| Interleukin-10 | 1 | 2019 | 67 | 0.150 |
Why?
|
| Biomarkers | 2 | 2023 | 736 | 0.150 |
Why?
|
| Sex Factors | 2 | 2017 | 451 | 0.150 |
Why?
|
| Mice, Knockout | 3 | 2021 | 792 | 0.150 |
Why?
|
| Age Factors | 2 | 2017 | 724 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 4 | 2021 | 318 | 0.150 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2017 | 9 | 0.140 |
Why?
|
| Area Under Curve | 1 | 2017 | 94 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 591 | 0.140 |
Why?
|
| Phenotype | 2 | 2021 | 667 | 0.140 |
Why?
|
| Peptides | 4 | 2013 | 283 | 0.140 |
Why?
|
| Linear Models | 1 | 2017 | 202 | 0.140 |
Why?
|
| Fibrosis | 1 | 2017 | 121 | 0.140 |
Why?
|
| Quantitative Trait Loci | 1 | 2017 | 57 | 0.140 |
Why?
|
| RNA Polymerase III | 1 | 1996 | 5 | 0.140 |
Why?
|
| Lymphocyte Subsets | 1 | 2016 | 8 | 0.130 |
Why?
|
| Immunoglobulin E | 1 | 2016 | 19 | 0.130 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 34 | 0.130 |
Why?
|
| Chemokine CXCL10 | 1 | 2016 | 22 | 0.130 |
Why?
|
| Logistic Models | 1 | 2017 | 399 | 0.130 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 472 | 0.130 |
Why?
|
| CD4 Antigens | 2 | 2023 | 18 | 0.130 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 93 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 448 | 0.130 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2016 | 66 | 0.120 |
Why?
|
| Genes, T-Cell Receptor alpha | 1 | 2015 | 2 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 1 | 1996 | 333 | 0.120 |
Why?
|
| Killer Cells, Natural | 1 | 2015 | 61 | 0.120 |
Why?
|
| Plasma Cells | 1 | 2014 | 21 | 0.120 |
Why?
|
| Th1 Cells | 1 | 2014 | 35 | 0.120 |
Why?
|
| ADAMTS13 Protein | 1 | 2015 | 126 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2021 | 111 | 0.110 |
Why?
|
| Recurrence | 1 | 2015 | 316 | 0.110 |
Why?
|
| HLA Antigens | 1 | 2023 | 57 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 455 | 0.110 |
Why?
|
| Genome, Human | 1 | 2023 | 71 | 0.110 |
Why?
|
| Adaptive Immunity | 1 | 2013 | 37 | 0.110 |
Why?
|
| Genetic Loci | 1 | 2013 | 78 | 0.110 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2012 | 7 | 0.100 |
Why?
|
| Mice, Inbred A | 2 | 2012 | 14 | 0.100 |
Why?
|
| DNA Methylation | 1 | 2014 | 150 | 0.100 |
Why?
|
| Furin | 1 | 2012 | 4 | 0.100 |
Why?
|
| Antitoxins | 1 | 2012 | 13 | 0.100 |
Why?
|
| Lethal Dose 50 | 1 | 2011 | 13 | 0.100 |
Why?
|
| DNA | 2 | 2012 | 365 | 0.090 |
Why?
|
| Immunity, Innate | 1 | 2013 | 211 | 0.090 |
Why?
|
| Species Specificity | 1 | 2011 | 187 | 0.090 |
Why?
|
| Antibody Formation | 2 | 2011 | 75 | 0.090 |
Why?
|
| Immunosuppressive Agents | 1 | 2012 | 142 | 0.090 |
Why?
|
| Protein Conformation | 2 | 2021 | 253 | 0.090 |
Why?
|
| Calcium Signaling | 2 | 2008 | 68 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2025 | 79 | 0.090 |
Why?
|
| Toxoplasma | 1 | 2010 | 32 | 0.080 |
Why?
|
| Nucleosomes | 1 | 2009 | 18 | 0.080 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2009 | 12 | 0.080 |
Why?
|
| Cross Reactions | 1 | 2009 | 72 | 0.080 |
Why?
|
| Cholesterol | 2 | 2007 | 181 | 0.080 |
Why?
|
| Histones | 1 | 2009 | 90 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2018 | 774 | 0.080 |
Why?
|
| Lymphopoiesis | 1 | 2009 | 22 | 0.080 |
Why?
|
| Myeloid Cells | 1 | 2009 | 27 | 0.080 |
Why?
|
| Antibodies | 1 | 2009 | 124 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 283 | 0.080 |
Why?
|
| Gene Expression | 2 | 2007 | 407 | 0.080 |
Why?
|
| Models, Molecular | 2 | 2021 | 445 | 0.080 |
Why?
|
| Amino Acid Sequence | 3 | 2021 | 679 | 0.070 |
Why?
|
| Models, Biological | 1 | 2010 | 448 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2007 | 20 | 0.070 |
Why?
|
| HLA-DQ beta-Chains | 1 | 2007 | 14 | 0.070 |
Why?
|
| Sequence Alignment | 2 | 1999 | 111 | 0.070 |
Why?
|
| Peptide Nucleic Acids | 1 | 2007 | 1 | 0.070 |
Why?
|
| HLA-DRB1 Chains | 1 | 2007 | 33 | 0.070 |
Why?
|
| Nephrosis, Lipoid | 1 | 2007 | 1 | 0.070 |
Why?
|
| Glomerular Basement Membrane | 1 | 2007 | 2 | 0.070 |
Why?
|
| Lymphocyte Count | 1 | 2007 | 14 | 0.070 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2007 | 13 | 0.070 |
Why?
|
| Membrane Microdomains | 1 | 2007 | 36 | 0.070 |
Why?
|
| Podocytes | 1 | 2007 | 10 | 0.070 |
Why?
|
| Iguanas | 2 | 1999 | 3 | 0.070 |
Why?
|
| Creatinine | 1 | 2007 | 57 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 80 | 0.070 |
Why?
|
| Protein Multimerization | 2 | 2021 | 53 | 0.070 |
Why?
|
| Oncogenes | 1 | 2007 | 34 | 0.070 |
Why?
|
| Haplotypes | 1 | 2007 | 279 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2022 | 666 | 0.070 |
Why?
|
| Models, Immunological | 1 | 2006 | 22 | 0.070 |
Why?
|
| RNA Stability | 1 | 2006 | 27 | 0.070 |
Why?
|
| Retina | 1 | 2010 | 421 | 0.070 |
Why?
|
| Trans-Activators | 1 | 2007 | 114 | 0.070 |
Why?
|
| Hybridomas | 1 | 2006 | 17 | 0.060 |
Why?
|
| Immunodominant Epitopes | 1 | 2006 | 13 | 0.060 |
Why?
|
| Injections, Subcutaneous | 1 | 2006 | 58 | 0.060 |
Why?
|
| Mucin-1 | 1 | 2006 | 35 | 0.060 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2005 | 4 | 0.060 |
Why?
|
| CD18 Antigens | 1 | 2005 | 14 | 0.060 |
Why?
|
| Adjuvants, Immunologic | 1 | 2006 | 63 | 0.060 |
Why?
|
| 3T3 Cells | 2 | 2021 | 45 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2005 | 32 | 0.060 |
Why?
|
| Kidney | 1 | 2007 | 275 | 0.060 |
Why?
|
| Receptors, Notch | 1 | 2005 | 44 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2006 | 97 | 0.060 |
Why?
|
| Models, Animal | 1 | 2006 | 128 | 0.060 |
Why?
|
| Genetic Association Studies | 2 | 2017 | 110 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2005 | 155 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 264 | 0.060 |
Why?
|
| Oxygen Consumption | 1 | 2025 | 179 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 400 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2025 | 184 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 482 | 0.050 |
Why?
|
| Vimentin | 1 | 2023 | 26 | 0.050 |
Why?
|
| ADAM17 Protein | 1 | 2021 | 13 | 0.050 |
Why?
|
| Thymocytes | 1 | 2021 | 12 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 49 | 0.050 |
Why?
|
| Ultraviolet Rays | 1 | 2021 | 41 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 100 | 0.050 |
Why?
|
| Saliva | 1 | 2021 | 94 | 0.050 |
Why?
|
| Adoptive Transfer | 1 | 2021 | 25 | 0.050 |
Why?
|
| Disulfides | 1 | 2021 | 33 | 0.050 |
Why?
|
| Germ Cells | 1 | 2021 | 15 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2021 | 176 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2021 | 130 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 83 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 447 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2021 | 152 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 658 | 0.040 |
Why?
|
| Chromosome Mapping | 2 | 2000 | 131 | 0.040 |
Why?
|
| Temperature | 1 | 2021 | 207 | 0.040 |
Why?
|
| Polymers | 1 | 2021 | 114 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2022 | 544 | 0.040 |
Why?
|
| Adolescent | 3 | 2016 | 2998 | 0.040 |
Why?
|
| Computational Biology | 1 | 2021 | 150 | 0.040 |
Why?
|
| Trout | 1 | 1999 | 1 | 0.040 |
Why?
|
| Ducks | 1 | 1999 | 3 | 0.040 |
Why?
|
| Anura | 1 | 1999 | 4 | 0.040 |
Why?
|
| Automation | 1 | 1999 | 19 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 1999 | 73 | 0.040 |
Why?
|
| United States | 2 | 2016 | 2063 | 0.040 |
Why?
|
| Cytokines | 1 | 2021 | 439 | 0.040 |
Why?
|
| Rabbits | 1 | 1999 | 275 | 0.040 |
Why?
|
| Glycosylation | 1 | 2018 | 69 | 0.040 |
Why?
|
| Tumor Virus Infections | 1 | 1997 | 14 | 0.040 |
Why?
|
| Capsid Proteins | 1 | 1997 | 12 | 0.040 |
Why?
|
| Herpesviridae Infections | 1 | 1997 | 17 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 1997 | 41 | 0.040 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1997 | 10 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2017 | 44 | 0.040 |
Why?
|
| Cattle | 1 | 1999 | 383 | 0.040 |
Why?
|
| Virus Diseases | 1 | 2017 | 38 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 1996 | 14 | 0.030 |
Why?
|
| Phylogeny | 1 | 1999 | 463 | 0.030 |
Why?
|
| HeLa Cells | 1 | 1997 | 206 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 347 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 1996 | 93 | 0.030 |
Why?
|
| Chromosomes | 1 | 1996 | 59 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 1996 | 163 | 0.030 |
Why?
|
| DNA Probes | 1 | 1995 | 12 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1995 | 47 | 0.030 |
Why?
|
| Xenopus | 1 | 1995 | 28 | 0.030 |
Why?
|
| Lip | 1 | 2014 | 10 | 0.030 |
Why?
|
| CpG Islands | 1 | 2014 | 24 | 0.030 |
Why?
|
| Europe | 1 | 2013 | 97 | 0.030 |
Why?
|
| Consensus | 1 | 2013 | 69 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2012 | 10 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 80 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2013 | 229 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2012 | 20 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2012 | 35 | 0.020 |
Why?
|
| Proteolysis | 1 | 2012 | 55 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2011 | 17 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2013 | 866 | 0.020 |
Why?
|
| B7-1 Antigen | 1 | 2010 | 11 | 0.020 |
Why?
|
| Bioterrorism | 1 | 2010 | 28 | 0.020 |
Why?
|
| B7-H1 Antigen | 1 | 2010 | 35 | 0.020 |
Why?
|
| Leukocytes | 1 | 2010 | 69 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2010 | 62 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2009 | 12 | 0.020 |
Why?
|
| Antigens, CD19 | 1 | 2009 | 12 | 0.020 |
Why?
|
| Immunoglobulin D | 1 | 2008 | 4 | 0.020 |
Why?
|
| Ionomycin | 1 | 2008 | 4 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2008 | 16 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2008 | 28 | 0.020 |
Why?
|
| Genes, Immunoglobulin | 1 | 2008 | 10 | 0.020 |
Why?
|
| Vaccination | 1 | 2010 | 172 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2008 | 59 | 0.020 |
Why?
|
| African Americans | 1 | 2011 | 348 | 0.020 |
Why?
|
| Tyrosine | 1 | 2008 | 92 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 1942 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2008 | 134 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 324 | 0.020 |
Why?
|
| Immunologic Capping | 1 | 2007 | 3 | 0.020 |
Why?
|
| Kinetics | 1 | 2008 | 538 | 0.020 |
Why?
|
| Antigens | 1 | 2007 | 66 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2007 | 71 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2008 | 567 | 0.020 |
Why?
|
| Leukocyte Common Antigens | 1 | 2007 | 17 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 2007 | 16 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 134 | 0.020 |
Why?
|
| Oklahoma | 1 | 2010 | 976 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 2006 | 11 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2006 | 11 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2007 | 197 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2009 | 398 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2006 | 109 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 298 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2006 | 377 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2007 | 514 | 0.010 |
Why?
|
| Appetite Regulation | 1 | 2000 | 2 | 0.010 |
Why?
|
| Exons | 1 | 2000 | 41 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2000 | 119 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 2288 | 0.010 |
Why?
|
| Genome | 1 | 2000 | 53 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 205 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1999 | 14 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 1997 | 23 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1997 | 50 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1997 | 74 | 0.010 |
Why?
|
| Prevalence | 1 | 1997 | 475 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1997 | 1102 | 0.010 |
Why?
|
| Child | 1 | 1997 | 2168 | 0.010 |
Why?
|